Improved detection of measurable residual disease in acute myeloid leukemia
Xuan Zhang1, H Leighton Grimes1
1Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Science Advances
|September 20, 2023
Abstract:
A novel multiplex single-cell genomic and immunophenotypic strategy leverages the sensitivity of MRD detection and distinguishes leukemic and preleukemic subpopulations.
More Related Videos
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
14.0K
07:39Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
170
